Article
Craspase Protease Activation Is Sensitive to Oncogenic Single-Nucleotide RNA Mismatches.
ACS chemical biology - 21 Aug 2026
Feldmann Dani, van Beljouw Sam P B, Haagsma Anna C, Kalogeropoulos Konstantinos, Muralidharan Aswin, Brouns Stan J J
Abstract excerpt
The type III-E CRISPR-controlled protease Craspase is distinguished from other type III systems by its single-subunit RNA-guided protein complex and direct coupling of RNA recognition to protease activation without second messenger signaling, making it an attractive development platform for bioengineering and therapeutics. Here, we identify five positions within the CRISPR RNA (crRNA) of Craspase from Candidatus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
